GRIFOLS | GRF - Ebitda

Stock Price
9.34
Daily Change
0.12 1.35%
Monthly
-17.03%
Yearly
-1.73%
Q1 Forecast
8.95

GRIFOLS reported EUR347.24M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alcon AG USD 317M 337M Dec/2025
Almirall EUR 114.07M 60.37M Dec/2025
Amadeus IT EUR 652.7M 5M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 387.05M 99.02M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Demant DKK 2.76B 165M Dec/2025
Ence Energia y Celulosa EUR 12.7M 10.8M Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Ferrovial EUR 542M 607M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 477M 101M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.97B 223M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 5.88B 290M Sep/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.03B 334M Jun/2025
Viscofan EUR 71.75M 1.33M Dec/2025